Menu Close

The Peter Doherty Institute for Infection and Immunity

The Doherty Institute is a world-class institute combining research, teaching, public health and reference laboratory services, diagnostic services and clinical care into infectious diseases and immunity. The establishment of the Doherty Institute represents a radical change in the capacity of Australia and the world to detect, investigate and respond to existing, emerging and re-emerging infectious diseases and agents, with a major focus on diseases that pose serious public and global health threats such as influenza, tuberculosis, HIV, viral hepatitis and drug resistant bacteria. The Doherty’s activities are multi-disciplinary and cross-sectoral, placing great emphasis on translational research and improving clinical outcomes. Teams of interdisciplinary scientists, clinicians and epidemiologists collaborate on a wide spectrum of activities - from basic immunology and discovery research, to the development of new vaccines and new preventative and treatment methods, to surveillance and investigation of disease outbreaks.

Links

Displaying 1 - 20 of 45 articles

Rates of resistance to the bacteria commonly known as golden staph are at least double in remote Indigenous communities what they are in Australia’s major cities. Lucy Hughes Jones/AAP

Antibiotic resistance is an even greater challenge in remote Indigenous communities

Antibiotic resistance is one of the greatest health challenges of the modern day. It's especially prevalent, and must be acted on, in Australia's remote Indigenous communities.
Around 5% of adults and 90% of babies who contract hepatitis B go on to have life-long infection that can only be managed with regular medication. Ronald Rampsch/Shutterstock

We have a vaccine for hepatitis B but here’s why we still need a cure

Babies in Australia have been vaccinated against hepatitis B since May 2000, but 240,000 Australians still live with the disease.
While hepatitis B can’t be cured in the same way hepatitis C can, effective treatment is available. From shutterstock.com

In contrast to Australia’s success with hepatitis C, our response to hepatitis B is lagging

Curing thousands of Australians with hepatitis C is one of the public health success stories of recent years. We can take lessons from this as we continue in the fight against hepatitis B.
First recognised ten years ago, Candida auris is a fungus within the genus Candida. From shutterstock.com

Explainer: what is Candida auris and who is at risk?

Candida auris is a fungus which breeds most commonly in health-care settings. It's cause for concern because it's hard to detect, and is resistant to many anti-fungal drugs.
Opportunities to help drive the energy transition are everywhere - even in Western Australia’s remote salt pans. Peter C. Doherty

We have so many ways to pursue a healthy climate – it’s insane to wait any longer

Nobel Prizewinning health researcher Peter Doherty reflects on the challenge of delivering a healthy climate for the world. From hydrogen power to wooden skyscrapers, the options are endless, but all require leadership.
Rita Levi-Montalcini celebrates her 100th birthday in 2009. Presidenza della Repubblica Italiana/Wikimedia Commons

Dismissed under Mussolini, later Nobel prize winner – the importance of scientist Rita Levi-Montalcini

Born in Italy in 1909, Levi-Montalcini avoided being transported to Auschwitz as a young woman and rose to prominence as a neurobiologist. She was a co-recipient of the 1986 Nobel Prize for Medicine.

Authors

More Authors